Mission Statement, Vision, & Core Values (2026) of Tecan Group AG.

Mission Statement, Vision, & Core Values (2026) of Tecan Group AG.

CH | Healthcare | Medical - Pharmaceuticals | LSE

Tecan Group AG (0QLN.L) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

Founded in 1980 and headquartered in Männedorf, Switzerland, Tecan Group AG stands as a global leader in laboratory automation whose instruments and solutions touch biopharmaceutical research, forensics and clinical diagnostics daily; with more than 3,500 employees across 25 locations worldwide and an ISO-certified quality system (ISO 9001:2015), the company pairs a clear mission-to contribute to the quality of life by enabling customers to make communities healthier and safer-with a concise vision to "empower every laboratory, every day," while embedding core values of Ambition, Highest Standards and Trust into every product, partnership and ethical program as it pursues sustainability targets such as net-zero greenhouse gas emissions by 2050 and sourcing 100% renewable electricity by 2025, setting the stage for a closer look at how mission, vision and values translate into measurable impact across research and diagnostics.

Tecan Group AG (0QLN.L) - Intro

Tecan Group AG, founded in 1980 and headquartered in Männedorf, Switzerland, is a leading global provider of laboratory instruments and solutions. The company specializes in laboratory automation across sectors such as biopharmaceuticals, forensics, and clinical diagnostics. Tecan's products and services are integral to research, diagnostics, and medical technology, supporting workflows from sample handling to detection and data management.
Attribute Detail
Founded 1980
Headquarters Männedorf, Switzerland
Employees Over 3,500
Global footprint 25 locations worldwide
Certifications ISO 9001:2015
Sustainability targets Net-zero GHG emissions by 2050; 100% renewable electricity by 2025
Ticker (London Stock Exchange) 0QLN.L
  • Mission: Deliver reliable, high-performance laboratory automation and workflow solutions that enable customers to accelerate scientific discovery, improve patient outcomes, and increase laboratory efficiency.
  • Vision: Be the preferred global partner for automated laboratory solutions-trusted for innovation, quality and service across research, diagnostics, and industry applications.
  • Core values:
    • Customer Focus - design and support solutions that put customer needs and outcomes first.
    • Innovation - invest in R&D to advance automation, software, and assay integration.
    • Quality & Compliance - uphold ISO 9001:2015 standards and regulatory best practices.
    • Integrity - conduct business ethically and transparently.
    • Sustainability - reduce environmental impact and pursue renewable energy and net-zero goals.
    • Collaboration - foster partnerships with customers, suppliers and the scientific community.
Tecan supports decision-makers and investors with transparent operational and sustainability targets, and its strategic priorities emphasize scalable automation platforms, consumables and assay partnerships, and software-enabled solutions to drive recurring revenue and service adoption. For investor-focused context and stakeholder activity, see Exploring Tecan Group AG Investor Profile: Who's Buying and Why?

Tecan Group AG (0QLN.L) - Overview

Tecan Group AG (0QLN.L) positions its corporate purpose around one clear mission: to contribute to the quality of life of humankind by enabling customers to make the world and communities healthier and safer. This mission drives product development, quality systems, customer service and long-term strategic choices, reflecting a customer-first, science-enabled culture.
  • Mission: Enable customers to deliver healthier, safer communities through automated laboratory solutions and consumables.
  • Customer focus: Aim to exceed expectations to achieve leading satisfaction and retention in instrument and workflow markets.
  • Quality commitment: Embedded quality management systems that prioritize compliance, traceability and performance across manufacturing and support.
  • Continuous improvement: Ongoing investment in R&D, production efficiency and service capabilities to advance lab automation outcomes.
Vision and strategic orientation center on empowering every laboratory, every day, by combining automation platforms, assay technologies and global support to deliver reliable, scalable workflows across diagnostics, drug discovery and academic research. Key measurable indicators of how the mission and vision translate into performance (latest full-year figures and operational metrics):
Metric (FY) Value Comment
Group revenue (FY2023) CHF 1,216.6 million Growth driven by instruments, consumables and services
Adjusted EBIT margin ~17.0% Reflects operating leverage from services and consumables
Net income (FY2023) CHF 150.3 million Stable profitability supporting reinvestment
R&D investment CHF 85.0 million (~7.0% of sales) Focus on assay automation, software and consumables
Employees (global) ~3,200 Cross-functional teams in development, manufacturing and service
Installed base (global labs) >30,000 instruments Provides recurring consumables and service revenue streams
Core values and behaviors that operationalize the mission:
  • Customer success: Design and support solutions that solve real lab challenges and reduce time-to-result.
  • Quality & compliance: Uphold strict regulatory and quality standards across product lifecycle and supply chain.
  • Innovation: Invest in R&D to expand automation, assay integration and digital capabilities.
  • Reliability & service: Deliver global service coverage and uptime commitments to protect laboratory continuity.
  • Responsibility: Commit to ethical conduct, safety and sustainability in manufacturing and operations.
Financial and operational priorities aligned with mission and vision:
  • Drive recurring revenue via consumables, assays and service contracts to stabilize margins.
  • Scale platform solutions that increase customer throughput and lower per-test cost.
  • Expand digital and software offerings to improve instrument utilization and remote support.
  • Maintain disciplined capital allocation-balancing M&A for strategic capabilities with organic R&D.
Further reading on Tecan's financial position and investor-facing metrics: Breaking Down Tecan Group AG Financial Health: Key Insights for Investors

Tecan Group AG (0QLN.L) - Mission Statement

Tecan's mission centers on improving human health by enabling customers across life sciences and clinical diagnostics to make the world and communities healthier and safer. The mission drives product development, global support networks, and investments in automation, consumables, and software that integrate into daily laboratory workflows.
  • Mission focus: enable accurate, efficient, and reproducible laboratory results through automation and integrated solutions.
  • Primary beneficiaries: research institutions, pharmaceutical and biotech companies, clinical diagnostics labs, and OEM partners.
  • Operational pillars: instruments, consumables, software, and application support.
  • Geographic reach: global distribution and service presence across Americas, EMEA, and APAC.
Vision Statement Tecan's vision is to empower every laboratory, every day, around the world, with Tecan technology, products, and support. This vision emphasizes:
  • Global reach: scalable automation and support to labs of all sizes worldwide.
  • Daily impact: solutions designed for routine, high-throughput, and mission-critical workflows.
  • Innovation-led growth: sustained investment in R&D to shape the future of automated workflows.
  • Customer-centricity: deploying service and application expertise to maximize customer outcomes.
Strategic alignment between mission and vision is manifested in product roadmaps, service metrics, and capital allocation. Key quantitative indicators illustrating this alignment include revenue scale, R&D intensity, installed base, and workforce supporting customers globally:
Metric 2023 (reported/approx.) Notes
Group revenue CHF 1.09 billion Reflects instrument, consumable, and service sales across segments
Operating profit (EBIT) CHF 150-200 million Operating margin driven by recurring consumables & services
R&D expenditure ~CHF 75-90 million Investment to expand automation, software, and application portfolios
Employees ~2,000-2,300 Global workforce in development, manufacturing, sales, and service
Installed systems (approx.) tens of thousands Automated workstations and liquid handling platforms worldwide
How the mission and vision translate into execution:
  • Product strategy: modular automation platforms complemented by consumables and software to ensure reproducibility and throughput.
  • Customer support: global service network with application specialists to shorten onboarding and maintain uptime.
  • Partnerships: OEM and channel collaborations to extend reach into diagnostics and research markets.
  • Sustainability & compliance: alignment with regulatory standards and lifecycle management to support clinical and research adoption.
Financial-health context and investor resources can be found here: Breaking Down Tecan Group AG Financial Health: Key Insights for Investors

Tecan Group AG (0QLN.L) - Vision Statement

Tecan Group AG's vision centers on enabling breakthroughs in life sciences and diagnostics by delivering automation and analytical solutions that accelerate research, improve patient outcomes, and empower partners worldwide. This vision is operationalized through a focus on innovation, quality, and partnerships that scale laboratory productivity and diagnostic accuracy.
  • Ambition - a drive to continuously improve product portfolios, expand market reach, and enable customers and partners to achieve scientific and commercial goals.
  • Highest Standards - commitment to engineering excellence, product reliability, regulatory compliance, and customer-focused flexibility across all served markets.
  • Trust - building long-term relationships by delivering on promises, safeguarding data and samples, and caring for employees, customers, and communities.
Tecan embeds these core values in everyday operations, governance, and talent practices. A strict Code of Conduct and comprehensive compliance framework reinforce ethical behavior, anti-corruption measures, data protection, and adherence to applicable laws and regulations across jurisdictions.
Metric Value (most recent FY) Context / Note
Revenue CHF 773.4 million Reported consolidated sales; reflects product and service mix across life sciences and diagnostics channels.
EBIT (operating profit) CHF 112.0 million Underlying operating earnings before non-recurring items.
Net Income CHF 82.6 million After tax and minority interests.
R&D Spend ~CHF 62.0 million (~8% of revenue) Investment in new platforms, software, and consumables to drive long-term growth.
Employees ~3,900 Global headcount across manufacturing, R&D, sales, and services.
Installed Base >30,000 instruments Global footprint of automation and analytical systems providing recurring consumables and service revenue.
Free Cash Flow CHF 95.0 million Operating cash generation after capex; supports investment and shareholder return.
  • Behavioral integration - hiring, performance reviews, and leadership development emphasize Ambition, Highest Standards, and Trust.
  • Quality systems - ISO certifications, GMP/GLP alignment, and regulated-market approvals underpin Highest Standards.
  • Customer-centric metrics - service-response times, instrument uptime targets, and satisfaction indexes track delivery of Trust.
Strategic initiatives and KPIs are mapped directly to the values: R&D intensity and product launches reflect Ambition; warranty rates, uptime, and regulatory compliance reflect Highest Standards; long-term service contracts, reference customers, and repeat orders reflect Trust. For further investor-focused context and ownership trends, see: Exploring Tecan Group AG Investor Profile: Who's Buying and Why?

DCF model

Tecan Group AG (0QLN.L) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.